Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipidrive Dietary Supplement Tolerance Study Based on Blood, Urine, and Hemodynamic Biological Parameters.

NCT03052062 is registered in ClinicalTrials.gov with Valbiotis as lead sponsor.

NCT NCT03052062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03052062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipidrive Dietary Supplement Tolerance Study Based on Blood, Urine, and Hemodynamic Biological Parameters.
Lead sponsor
Valbiotis
Phase
Phase 1/2
Overall status
Completed
Start date
March 2, 2017
Completion date
July 3, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obese